Literature DB >> 20470256

Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors.

Larissa Fabritz1, Paulus Kirchhof.   

Abstract

In addition to their therapeutic effect, all drugs have unwanted effects. For the purpose of this MiniReview, unwanted drug effects will be discussed as either predictable, dose-dependent effects, or as less predictable events which only occur in patients pre-disposed to unwanted drug reactions when confronted with specific situations. While clinicians have long been using biomarkers to identify patients prone to less predictable unwanted drug effects, emerging data clearly suggest that such effects are often a consequence of interactions between drug effects, drug metabolism, an individual, at times genetically conferred pre-disposition to the interaction, and transient pre-disposing factors. This paper describes general principles of predictable and less predictable unwanted drug effects and discusses the complex interplay of genetic and acquired pre-disposing and precipitating factors for such effects using the example of ventricular pro-dysrhythmia. The latter, an important unwanted effect of many drugs, is a common yet not fully understood less predictable cardiac drug effect. Understanding the mechanisms of ventricular pro-dysrhythmia may allow to predict this unwanted drug effect better, and to identify novel markers for such events in the future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470256     DOI: 10.1111/j.1742-7843.2010.00547.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Investigation of mechanism of drug-induced cardiac injury and torsades de pointes in cynomolgus monkeys.

Authors:  D L Misner; C Frantz; L Guo; M R Gralinski; P B Senese; J Ly; M Albassam; K L Kolaja
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  [Atrial fibrillation: current recommendations for diagnosis and treatment].

Authors:  P Kirchhof
Journal:  Internist (Berl)       Date:  2013-05       Impact factor: 0.743

4.  The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology.

Authors:  Paulus Kirchhof; Karin R Sipido; Martin R Cowie; Thomas Eschenhagen; Keith A A Fox; Hugo Katus; Stefan Schroeder; Heribert Schunkert; Silvia Priori
Journal:  Eur Heart J       Date:  2014-08-22       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.